{"paper_id":"83e605ec-0707-4eea-8042-2e260c65d4f6","body_text":"Published online by Cambridge University Press: 10 March 2009\nMenorrhagia can be treated by drug therapy or surgery. General practitioners (GPs) can prescribe drugs to reduce menstrual blood loss as first-line treatment, referring patients for surgical treatment if drug therapy fails. This study examined the efficacy of drugs used to treat menorrhagia and surveyed British GPs to discover the extent to which they prescribed the most effective drugs for this condition. The results suggest that treatment of this condition in primary care falls short of desirable standards. A meta-analysis of randomized trials of drug therapy revealed wide differences in efficacy and side effects. The most effective drug (tranexamic acid) is little used by British GPs, whereas the least effective drug (norethisterone) is the most frequently prescribed.\n- Type\n- Special Section: The Rational Use of Therapeutic Drugs\n- Information\n- International Journal of Technology Assessment in Health Care , Volume 11 , Issue 3 , Summer 1995 , pp. 456 - 471\n- Copyright\n- Copyright © Cambridge University Press 1995\n1.Andersch, B., Milson, I., & Rybo, G.An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia. Acta Obstethcia et Gynecologica Scandinavica, 1988, 67, 645–48.CrossRefGoogle ScholarPubMed\n2.Bonnar, J. Seminar on dysfunctional uterine bleeding (unpublished). London: The Royal Society of Medicine, 1994.Google Scholar\n3.Callender, S., Warner, G., & Cope, E.Treatment of menorrhagia with tranexamic acid: A double-blind trial. British Medical Journal, 1970, 4, 214–16.CrossRefGoogle ScholarPubMed\n4.Cameron, I., Haining, R., Lumsden, M.-A., et al. The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Obstetrics and Gynecology, 1990, 76, 85–88.Google ScholarPubMed\n5.Cameron, I., Leask, R., Kelly, R., & Baird, D.The effects of danazol, mefenamic acid, norethisterone, and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandins, 1987, 34, 99–110.CrossRefGoogle Scholar\n6.Chamberlain, G., Freeman, R., Price, F., et al. A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding. British Journal of Obstetrics and Gynaecology, 1991, 98, 707–11.CrossRefGoogle ScholarPubMed\n7.Chimbira, T., Anderson, A., Naish, C., et al. Reduction of menstrual blood loss by danazol in unexplained menorrhagia: Lack of effect of placebo. British Journal of Obstetrics and Gynaecology, 1980, 87, 1152–58.CrossRefGoogle ScholarPubMed\n8.Chimbira, T., Anderson, A., & Turnbull, A.Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area. British Journal of Obstetrics and Gynaecology, 1980, 87, 603–09.CrossRefGoogle ScholarPubMed\n9.Coulter, A., Klassen, A., MacKenzie, I., & McPherson, K.Diagnostic dilatation and curettage: Is it used appropriately? British Medical Journal, 1993, 306, 236–39.CrossRefGoogle ScholarPubMed\n10.Coulter, A., Klassen, A., & McPherson, K. How many hysterectomies should purchasers buy? European Journal of Public Health, in press, 1995.CrossRefGoogle Scholar\n11.Coulter, A., & McPherson, K.The hysterectomy debate. Quarterly Journal of Social Affairs, 1986, 2, 379–96.Google Scholar\n12.Davis, A., Anderson, A., & Turnbull, A.Reduction by naproxen of excessive menstrual bleeding in women using intrauterine devices. Obstetrics and Gynecology, 1981, 57, 74–78.Google Scholar\n13.Dockeray, C., Shephard, B., & Bonnar, J.Comparison between mefenamic acid and danazol in the treatment of established menorrhagia. British Journal of Obstetrics and Gynaecology, 1989, 96, 840–44.CrossRefGoogle ScholarPubMed\n14.Fraser, I., & McCarron, G.Randomized trial of two hormonal and two prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Australian New Zealand Journal of Obstetrics and Gynaecology, 1991, 31, 66–70.CrossRefGoogle Scholar\n15.Fraser, I., McCarron, G., & Markham, R.A preliminary study of factors influencing perception of menstrual blood loss volume. American Journal of Obstetrics, 1984, 149, 788–93.CrossRefGoogle ScholarPubMed\n16.Fraser, I., Pearse, C., Shearman, R., et al. Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstetrics and Gynecology, 1981, 58, 543–51.Google ScholarPubMed\n17.Gallegos, A., Aznar, R., Merino, G., & Guizer, E.Intrauterine devices and menstrual blood loss: A comparative study of eight devices during the first six months of use. Contraception, 1978, 17, 153–61.CrossRefGoogle Scholar\n18.Guillebaud, I., Anderson, A., & Turnball, A.Reduction by mefenamic acid of increased menstrual blood loss associated with intrauterine contraception. British Journal of Obstetrics and Gynaecology, 1978, 85, 53–62.CrossRefGoogle ScholarPubMed\n19.Hall, P., MacLachlan, N., Thorn, N., et al. Control of menorrhagia by the cyclo-oxygenase inhibitors naproxan sodium and mefenamic acid. British Journal of Obstetrics and Gynaecology, 1987, 94, 554–58.CrossRefGoogle ScholarPubMed\n20.Hallberg, L., Hogdahl, A., Nilsson, L., & Rybo, G.Menstrual blood loss: A population study. Acta Obstetrica Gynecologica Scandinavica, 1966, 45, 320–51.CrossRefGoogle ScholarPubMed\n21.Hallberg, L., & Nilsson, L.Determination of menstrual blood loss. Scandinavian Journal of Clinical & Laboratory Investigation, 1964, 16, 244–48.CrossRefGoogle ScholarPubMed\n22.Harrison, R., & Campbell, S.A double-blind trial by ethamsylate in the treatment of primary and intrauterine device menorrhagia. Lancet, 1976, ii, 283–85.CrossRefGoogle Scholar\n23.Haynes, P., Anderson, A., & Turnbull, A.Patterns of menstrual blood loss in menorrhagia. Research and Clinical Forums, 1979, 1, 73–78.Google Scholar\n24.Haynes, P., Hodgson, H., Anderson, A., & Turnbull, A.Measurement of menstrual blood loss in patients complaining of menorrhagia. British Journal of Obstetrics and Gynaecology, 1977, 84, 763–68.CrossRefGoogle ScholarPubMed\n25.Higham, I., & Shaw, R.A comparative study of danazol, a regimen of decreasing doses of danazol and norethindrone in the treatment of objectively proven unexplained menorrhagia. American Journal of Obstetrics and Gynecology, 1993, 169, 1134–39.CrossRefGoogle ScholarPubMed\n26.Ingemanson, C., Sikstrom, B., Rybo, G., & Bjorkman, R.Double-blind, placebo-controlled evaluation of diclofenac in the management of patients with IUD-related menorrhagia. Advanced Therapeutics, 1991, 8, 287–92.Google Scholar\n28.Kasonde, J., & Bonnar, J.Effect of ethamsylate and aminocaproic acid on menstrual blood loss in women using intrauterine devices. British Medical Journal, 1975, 2, 21–22.CrossRefGoogle Scholar\n29.Macdonald, R.Modern treatment of menorrhagia. British Journal of Obstetrics and Gynaecology, 1990, 97, 3–7.CrossRefGoogle ScholarPubMed\n30.Makarainen, L., & Ylikorkala, O.Primary and myoma-associated menorrhagia: Role of prostaglandins and effects of ibuprofen. British Journal of Obstetrics and Gynaecology, 1986, 93, 974–78.CrossRefGoogle ScholarPubMed\n31.Milsom, I., Andersson, K., Andersch, B., & Rybo, G.A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. American Journal of Obstetrics and Gynecology, 1991, 164, 879–83.CrossRefGoogle Scholar\n32.Muggeridge, J., & Elder, M.Mefenamic acid in the treatment of menorrhagia. Research and Clinical Forums, 1983, 5, 83–88.Google Scholar\n33.Nilsson, C.Comparative quantitation of menstrual blood loss with a d-norgestrel-releasing IUD and a Nova-T-copper device. Contraception, 1977, 15, 379–87.CrossRefGoogle Scholar\n34.Nilsson, L., & Rybo, G.Treatment of menorrhagia with an antifibrinolytic agent, tranexamic acid (AMCA): A double-blind investigation. Acta Obstetricia et Gynecologica Scandinavica, 1967, 46, 572–80.CrossRefGoogle Scholar\n35.Preston, J., Cameron, I., Adams, E., & Smith, S.Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. British Journal of Obstetrics and Gynaecology, 1995, 102, 401–06.CrossRefGoogle ScholarPubMed\n36.Rees, M.Role of menstrual blood loss measurement in management of complaints of excessive menstrual bleeding. British Journal of Obstetrics and Gynaecology, 1991, 98, 327–28.CrossRefGoogle ScholarPubMed\n37.Rees, M., Canate-Soler, R., Lopez-Bernal, A., & Turnbull, A.Effect of fenamates on prostaglandin E receptor binding. Lancet, 1988, ii, 541–42.CrossRefGoogle Scholar\n38.Roy, S., & Shaw, S.Role of prostaglandins in IUD-associated uterine bleeding: Effect of a prostaglandin synthetase (ibuprofen). Obstetrics and Gynecology, 1981, 58, 101–06.Google ScholarPubMed\n39.Rybo, G.Tranexamic acid therapy effective treatment in heavy menstrual bleeding: Clinical update on safety. Therapeutic Advances, 1991, 4, 1–8.Google Scholar\n40.Rybo, G., Nilsson, S., Sikstrom, B., & Nygren, K.Naproxen in menorrhagia (letter). Lancet, 1981, i, 608–09.CrossRefGoogle Scholar\n41.Van Eijkeren, M., Christiaens, G., Gueze, H., & Sixma, J.Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. American Journal of Obstetrics and Gynecology, 1992, 166, 1419–28.CrossRefGoogle ScholarPubMed\n42.Vargyas, J., Campeau, J., & Mishell, D.Treatment of menorrhagia with meclofenamate sodium. American Journal of Obstetrics and Gynecology, 1987, 157, 944–50.CrossRefGoogle ScholarPubMed\n43.Vermylen, J., Verhaegen-Declercq, M., Verstraete, M., & Fierens, F.A double-blind study of the effect of tranexamic acid in essential menorrhagia. Thrombosis et Diathesis Haemorrhagica, 1968, 20, 583–87.Google ScholarPubMed\n44.Vessey, M., Villard-Mackintosh, L., McPherson, K., Coulter, A., & Yeates, D.The epidemiology of hysterectomy: Findings in a large cohort study. British Journal of Obstetrics and Gynaecology, 1992, 99, 402–07.CrossRefGoogle Scholar\n45.Ylikorkala, O., & Pekonen, F.Naproxen reduced idiopathic but not fibroma-induced menorrhagia. Obstetrics and Gynecology, 1986, 68, 10–12.Google ScholarPubMed\n46.Ylikorkala, O., & Viinikka, L.Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices. British Journal of Obstetrics and Gynaecology, 1983, 90, 78–83.CrossRefGoogle ScholarPubMed\n- 77\n- Cited by\nCited by\nCrossref Citations\nFarquhar, Cynthia M.\n1996.\nThe need for systematic reviews in the treatment of menstrual disorders–another Cochrane collaborative review group is born.\nBJOG: An International Journal of Obstetrics & Gynaecology,\nVol. 103,\nIssue. 6,\np.\n497.\nFarquhar, Cindy\nand\nVandekerckhove, Patrick\n1996.\n3 The Cochrane Library.\nBaillière's Clinical Obstetrics and Gynaecology,\nVol. 10,\nIssue. 4,\np.\n569.\nCoulter, Angela\n1996.\n12 Theory into practice: applying the evidence across the health service.\nBaillière's Clinical Obstetrics and Gynaecology,\nVol. 10,\nIssue. 4,\np.\n715.\nLilford, R J\n1997.\nHysterectomy: will it pay the bills in 2007?.\nBMJ,\nVol. 314,\nIssue. 7075,\np.\n160.\nChapple, Alison\nLing, Margaret\nand\nMay, Carl\n1997.\nMenorrhagia: The need for equity in treatment in Britain.\nReproductive Health Matters,\nVol. 5,\nIssue. 9,\np.\n132.\nLethaby, A\nIrvine, G\nCameron, I\nand\nLethaby, Anne\n1998.\nCochrane Database of Systematic Reviews.\nIrvine, G. A.\nCampbell‐Brown, M. B.\nLumsden, M. A.\nHeikkilä, A.\nWalker, J. J.\nand\nCameron, I. T.\n1998.\nRandomised comparative trial of the intrauterine system and norethisterone levonor gestrel for treatment of idiopathic menorrhagia.\nBJOG: An International Journal of Obstetrics & Gynaecology,\nVol. 105,\nIssue. 6,\np.\n592.\nDuckitt, Kirsten\n1998.\nEndometrial Ablative Techniques in the Climacteric Woman.\nBritish Menopause Society Journal,\nVol. 4,\nIssue. 3,\np.\n108.\nSculpher, Mark\n1998.\nA Cost-Utility Analysis of Abdominal Hysterectomy Versus Transcervical Endometrial Resection for the Surgical Treatment of Menorrhagia.\nInternational Journal of Technology Assessment in Health Care,\nVol. 14,\nIssue. 2,\np.\n302.\nDuckitt, Kirsten\nand\nShaw, Robert W.\n1998.\nIs medical management of menorrhagia obsolete?.\nBJOG: An International Journal of Obstetrics & Gynaecology,\nVol. 105,\nIssue. 6,\np.\n569.\nLähteenmäki, Pekka\nPrentice, Andrew\nHaukkamaa, Maija\nPuolakka, Jukka\nRiikonen, Ulla\nSainio, Susanna\nSuvisaari, Janne\nand\nNilsson, Carl Gustaf\n1998.\nOpen randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomyCommentary: Promising results but wider recruitment needed.\nBMJ,\nVol. 316,\nIssue. 7138,\np.\n1122.\nLethaby, Anne\nShepperd, Sasha\nFarquhar, Cindy\nCooke, Inez\nand\nLethaby, Anne\n1999.\nCochrane Database of Systematic Reviews.\nWinsor, S.H.M.\nFisher, S.\nHahn, P.M.\nand\nReid, R.L.\n1999.\nRetrospective Evaluation of the Long-Term Outcomes Following Conservative Management of Menorrhagia in Ovulatory Women.\nJournal SOGC,\nVol. 21,\nIssue. 2,\np.\n155.\nLethaby, AE\nCooke, I\nand\nRees, M\n1999.\nThe Cochrane Database of Systematic Reviews.\nHARLOW, SIOBÁN D.\n2000.\nWomen and Health.\np.\n99.\nGrant, Clare\nGallier, Lesley\nFahey, Tom\nPearson, Nicky\nand\nSarangi, Joyshri\n2000.\nManagement of menorrhagia in primary care—impact on referral and hysterectomy: data from the Somerset Morbidity Project.\nJournal of Epidemiology and Community Health,\nVol. 54,\nIssue. 9,\np.\n709.\nSculpher, Mark\nThompson, Elizabeth\nBrown, Jim\nand\nGarry, Ray\n2000.\nA cost effectiveness analysis of goserelin compared with danazol as endometrial thinning agents.\nBJOG: An International Journal of Obstetrics & Gynaecology,\nVol. 107,\nIssue. 3,\np.\n340.\nLethaby, Anne\nFarquhar, Cindy\nand\nCooke, Inez\n2000.\nAntifibrinolytics for heavy menstrual bleeding.\nCochrane Database of Systematic Reviews,\nLee, Joseph Y.\nHahn, Philip M.\nVan Dijk, Janice P.\nand\nReid, Robert L.\n2000.\nTreatment of Menorrhagia with Tranexamic Acid.\nJournal SOGC,\nVol. 22,\nIssue. 10,\np.\n794.\nO’Flynn, Norma\nand\nBritten, Nicky\n2000.\nMenorrhagia in general practice — disease or illness.\nSocial Science & Medicine,\nVol. 50,\nIssue. 5,\np.\n651.","source_license":"CC0","license_restricted":false}